Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian L Harris

Showing results (221-230 of 464) with videos related to

Pageof 47
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
BNIP3 as a progression marker in primary human breast cancer; opposing functions in in situ versus invasive cancerErn Yu Tan, Leticia Campo, Cheng Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancerJane L Boddy, Stephen B Fox, Cheng Han, et al.
The Journal of Pathology|May 20, 2003
Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancerCory S M Williams, Russell D Leek, Alistair M Robson, et al.
The Prostate|May 5, 2007
Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxiaAlison H Banham, Jane Boddy, Rosalind Launchbury, et al.
Scientific Reports|June 25, 2020
Role of gene signatures combined with pathology in classification of oropharynx head and neck cancerAndrew Dhawan, Jacob Scott, Purnima Sundaresan, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 21, 2012
Inhibition of carbonic anhydrase activity modifies the toxicity of doxorubicin and melphalan in tumour cells in vitroRoben G Gieling, Catriona A Parker, Lisa A De Costa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancerCarme Camps, Francesca M Buffa, Stefano Colella, et al.
The Prostate|March 1, 2007
The number of regulatory T cells in prostate cancer is associated with the androgen receptor and hypoxia-inducible factor (HIF)-2alpha but not HIF-1alphaStephen B Fox, Rosalind Launchbury, Gaynor J Bates, et al.
Plos Computational Biology|November 26, 2009
Exon array analysis of head and neck cancers identifies a hypoxia related splice variant of LAMA3 associated with a poor prognosisCarla S Moller-Levet, Guy N J Betts, Adrian L Harris, et al.
Genome Biology|July 1, 2016
Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxiaSyed Haider, Alan McIntyre, Ruud G P M van Stiphout, et al.
Pageof 47

Showing results (221-230 of 464) with videos related to

Sort By:
Pageof 47
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
BNIP3 as a progression marker in primary human breast cancer; opposing functions in in situ versus invasive cancerErn Yu Tan, Leticia Campo, Cheng Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancerJane L Boddy, Stephen B Fox, Cheng Han, et al.
The Journal of Pathology|May 20, 2003
Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancerCory S M Williams, Russell D Leek, Alistair M Robson, et al.
The Prostate|May 5, 2007
Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxiaAlison H Banham, Jane Boddy, Rosalind Launchbury, et al.
Scientific Reports|June 25, 2020
Role of gene signatures combined with pathology in classification of oropharynx head and neck cancerAndrew Dhawan, Jacob Scott, Purnima Sundaresan, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 21, 2012
Inhibition of carbonic anhydrase activity modifies the toxicity of doxorubicin and melphalan in tumour cells in vitroRoben G Gieling, Catriona A Parker, Lisa A De Costa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancerCarme Camps, Francesca M Buffa, Stefano Colella, et al.
The Prostate|March 1, 2007
The number of regulatory T cells in prostate cancer is associated with the androgen receptor and hypoxia-inducible factor (HIF)-2alpha but not HIF-1alphaStephen B Fox, Rosalind Launchbury, Gaynor J Bates, et al.
Plos Computational Biology|November 26, 2009
Exon array analysis of head and neck cancers identifies a hypoxia related splice variant of LAMA3 associated with a poor prognosisCarla S Moller-Levet, Guy N J Betts, Adrian L Harris, et al.
Genome Biology|July 1, 2016
Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxiaSyed Haider, Alan McIntyre, Ruud G P M van Stiphout, et al.
Pageof 47